Quick Answer
AtriCure, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $534.53 million for the year ending 2025.
- AtriCure, Inc. showed an increase of +14.9% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from AtriCure, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $42.15 million | Q1 2018: $46.99 million | Q2 2018: $51.80 million | Q3 2018: $49.94 million | Q4 2018: $52.89 million | Q1 2019: $53.97 million | Q2 2019: $58.91 million | Q3 2019: $56.61 million | Q4 2019: $61.32 million | Q1 2020: $53.23 million | Q2 2020: $40.82 million | Q3 2020: $54.76 million | Q4 2020: $57.73 million | Q1 2021: $59.28 million | Q2 2021: $71.38 million | Q3 2021: $70.46 million | Q4 2021: $73.22 million | Q1 2022: $74.58 million | Q2 2022: $84.53 million | Q3 2022: $83.25 million | Q1 2023: $93.49 million | Q2 2023: $100.92 million | Q3 2023: $98.29 million | Q1 2024: $108.85 million | Q2 2024: $116.27 million | Q3 2024: $115.91 million | Q1 2025: $123.62 million | Q2 2025: $136.14 million | Q3 2025: $134.27 million.
- Over the full 10 years of available data (2016 to 2025), AtriCure, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 244.6%.
- Historical annual values: Fiscal year 2025: $534.53 million | Fiscal year 2024: $465.31 million | Fiscal year 2023: $399.25 million | Fiscal year 2022: $330.38 million | Fiscal year 2021: $274.33 million | Fiscal year 2020: $206.53 million | Fiscal year 2019: $230.81 million | Fiscal year 2018: $201.63 million | Fiscal year 2017: $174.72 million | Fiscal year 2016: $155.11 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: